Camidanlumab, CAS 921618-45-3

Product Description: Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Michael J Flynn, et al. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. Mol Cancer Ther. 2016 Nov;15(11):2709-2721.

CAS Number: 921618-45-3

Molecular Weight: N/A

Compound Purity: 99.23

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99233-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99233-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK